Form 4 for YCBD cbdMD, Inc.
Accepted 2025-12-19 00:00:00 ET · period of report 2025-12-17 · accession 0001213900-25-123549 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-12-19 | 2025-12-17 | YCBD | Crosnoe Clark R. | 10% | S - Sale | $2.31 | -550.7K | 361.4K | -60% | -$1.27M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-17 | S | D | 69,875 | $2.34 | 56,875 | I By NM 2018 Trust | — | — | (F1) The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
| 2 | Common | Common Stock | 2025-12-17 | S | D | 19,101 | $2.34 | 17,875 | I By AMC Legacy Trust | — | — | (F1) The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
| 3 | Common | Common Stock | 2025-12-17 | S | D | 461,725 | $2.31 | 361,400 | I By CRC Investment Fund LP | — | — | (F1) The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |